In a multivariable analysis, stratification of patients into “CD47 high” and “CD47 low” groups indicated that high CD47 mRNA expression levels could decrease the OS and PFS in patients with AC (Figure 2A), SCC (Figure 2B), and SCLC (Figure 2C). The gene discussed is CD47; the disease is small cell lung carcinoma.